triazolam has been researched along with Liver Failure in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Liver Failure: Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanda, T | 1 |
| Yokosuka, O | 1 |
| Fujiwara, K | 1 |
| Saisho, H | 1 |
| Shiga, H | 1 |
| Oda, S | 1 |
| Okuda, K | 1 |
| Sugawara, Y | 1 |
| Makuuchi, M | 1 |
| Hirasawa, H | 1 |
1 other study available for triazolam and Liver Failure
| Article | Year |
|---|---|
Fulminant hepatic failure associated with triazolam.
Topics: Anti-Anxiety Agents; Female; Humans; Liver Failure; Middle Aged; Sleep Initiation and Maintenance Di | 2002 |